Albemarle (ALB) is facing "increased spot market risk" and its management has been building the company's resilience for it, Oppenheimer said in a Friday note.
"We are encouraged by the prospect of Albemarle being free cash flow positive in 2025, despite a higher percentage of spot sales and continued anemic spot prices," the investment firm said. According to Oppenheimer, Albemarle's cost cuts and spot prices' recovery from Q3 lows led to its improved Q4 gross margin.
Oppenheimer also said it expects lithium demand to remain robust, but sees a U-shaped recovery for prices as the sector halts capacity expansion with the backdrop of flat to higher in the US and the European Union and growing electric vehicle sales in China.
Oppenheimer lowered its price target on Albemarle's stock to $123, from $170 due to a cautious view on 2025 and 2026 pricing, while reiterating an outperform rating.
Price: 80.84, Change: +1.58, Percent Change: +2.00
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。